Nyrada

(ASX) NYR

Current PriceA$0.44

Market CapA$107.03M

Since IPO (2020)+91%

5 Year+40%

1 Year+132%

1 Month-20%

Nyrada Financials at a Glance

Market Cap

A$107.03M

Revenue (TTM)

A$3.25M

Net Income (TTM)

-A$9.56M

EPS (TTM)

-A$0.02

P/E Ratio

-17.67

Dividend

A$0.00

Beta (Volatility)

0.03 (Low)

Dividend

A$0.00

Beta (Volatility)

0.03 (Low)

Price

A$0.44

Volume

117,411

Open

A$0.45

Price

A$0.44

Volume

117,411

Open

A$0.45

Previous Close

A$0.44

Daily Range

A$0.44 - A$0.46

52-Week Range

A$0.19 - A$1.44

Estimated Earnings Date

Feb 16, 2026

Dividend

A$0.00

Beta (Volatility)

0.03 (Low)

Price

A$0.44

Volume

117,411

Open

A$0.45

Previous Close

A$0.44

Daily Range

A$0.44 - A$0.46

52-Week Range

A$0.19 - A$1.44

Estimated Earnings Date

Feb 16, 2026

NYR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nyrada

Industry

Pharmaceuticals

Sector

Health Care

CEO

James Bonnar

Website

www.nyrada.com

Headquarters

Gordon, NSW 2072, AU

NYR Financials

Key Financial Metrics (TTM)

Gross Margin

-61%

Operating Margin

-6%

Net Income Margin

-3%

Return on Equity

-71%

Return on Capital

-90%

Return on Assets

-54%

Earnings Yield

-5.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$107.03M

Shares Outstanding

243.26M

Volume

117.41K

Avg. Volume

244.20K

Financials (TTM)

Gross Profit

-A$1.98M

Operating Income

-A$9.20M

EBITDA

-A$5.00M

Operating Cash Flow

-A$5.05M

Capital Expenditure

A$0.00

Free Cash Flow

-A$5.05M

Cash & ST Invst.

A$2.93M

Total Debt

A$0.00

Nyrada Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$1.46K

-100.1%

Gross Margin

0.00%

N/A

Market Cap

A$107.03M

N/A

Market Cap/Employee

A$107.03M

N/A

Employees

N/A

Net Income

-A$3.18M

-2451.6%

EBITDA

-A$4.01M

-79.7%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$7.12M

+53.3%

Total Debt

A$0.00

N/A

Accounts Receivable

A$3.02M

+1256.5%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-53.59%

N/A

Return on Invested Capital

-89.80%

N/A

Free Cash Flow

-A$4.46M

-576.9%

Operating Cash Flow

-A$4.46M

-576.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ILA.AXIsland Pharmaceuticals Limited

ILA.AXIsland Pharmaceuticals LimitedA$0.38+7.04%

ACW.AXActinogen Medical Limited

ACW.AXActinogen Medical LimitedA$0.03+0.00%

AHC.AXAustco Healthcare Limited

AHC.AXAustco Healthcare LimitedA$0.23+2.27%

AVH.AXAVITA Medical, Inc.

AVH.AXAVITA Medical, Inc.A$1.08-5.68%

RCE.AXRecce Pharmaceuticals Ltd

RCE.AXRecce Pharmaceuticals LtdA$0.50+2.04%

EMV.AXEMVision Medical Devices Ltd

EMV.AXEMVision Medical Devices LtdA$1.57-1.88%

PAR.AXParadigm Biopharmaceuticals Limited

PAR.AXParadigm Biopharmaceuticals LimitedA$0.15+3.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About NYR

What is the current price of Nyrada?

Nyrada is trading at A$0.44 per share.

What is the 52-week range for Nyrada?

Over the past 52 weeks, Nyrada has traded between A$0.19 and A$1.44.

How much debt does Nyrada have?

As of the most recent reporting period, Nyrada reported total debt of A$0.00.

How much cash does Nyrada have on hand?

Nyrada reported A$2.93M in cash and cash equivalents in its most recent financial results.

What is Nyrada’s dividend yield?

Nyrada does not currently have a dividend yield.

Nyrada

Nyrada Financials at a Glance

NYR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nyrada

NYR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nyrada Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NYR

What is the current price of Nyrada?

What is the 52-week range for Nyrada?

How much debt does Nyrada have?

How much cash does Nyrada have on hand?

What is Nyrada’s dividend yield?

Premium Investing Services